The system, which received 510(k) clearance from the U.S. Food and Drug Administration in March, is a growth-friendly solution for pediatric patients, younger than 10 years, with severe progressive spinal deformities associated with thoracic insufficiency syndrome. It provides an alternative to traditional growing rods.
A medical technology guidance from NICE encouraged the NHS to use the MAGEC system in children who suffer from early onset scoliosis. This was then followed by a published draft policy by NHS with a similar endorsement.
To date, the system has been used by more than 200 surgeons in 24 countries.
More Articles on Devices:
5 Key Results: LDR’s Mobi-C Artificial Disc Replacement vs. ACDF
FDA Clears AccelSPINE’s Next Generation Minimally Invasive Spine System
Global Medical Device Market to Grow at 6.2% Annually Until 2018
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
